Vertex/ US92538J1060 /
2024-11-15 9:59:58 PM | Chg. -0.41 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
49.07USD | -0.83% | 37,680 Turnover: 1.86 mill. |
-Bid Size: - | -Ask Size: - | 50.06 | 48.85 |
GlobeNewswire
08-28
Hematologists Highlight Ongoing Challenges in Sickle Cell Disease and Thalassemia Amidst Promising A...
GlobeNewswire
08-19
Orby Expands Industry’s Leading Research, Machine Learning And Foundation Model Team
GlobeNewswire
08-12
Xometry Unveils Instant Pricing, Lead Time Offerings For Tube Cutting, Tube Bending
GlobeNewswire
08-06
MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guida...
GlobeNewswire
08-05
Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update
GlobeNewswire
08-05
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
GlobeNewswire
07-25
Vertex 2024 Mid-Year Sales Tax Rates and Rules Report Reveals Local Governments are Increasingly Dep...
GlobeNewswire
07-18
Agilon Health, Inc, B. Riley Financial, Charles River Laboratories, and Vertex Energy Investigation ...
GlobeNewswire
07-16
Jeito Capital consolidates its support in CatalYm with a renewed participation in a $150 million fi...
GlobeNewswire
07-11
Vertex to Announce Second Quarter 2024 Financial Results on Wednesday, August 7, 2024